Cargando…
Brain Metastasis in Pancreatic Cancer
Pancreatic cancer is a fatal disease with a 5-year survival rate below 5%. Most patients are diagnosed at an advanced tumor stage and existence of distant metastases. However, involvement of the central nervous system is rare in pancreatic cancer. We retrospectively analyzed all cases of brain metas...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3588092/ https://www.ncbi.nlm.nih.gov/pubmed/23429199 http://dx.doi.org/10.3390/ijms14024163 |
_version_ | 1782261497482706944 |
---|---|
author | Lemke, Johannes Scheele, Jan Kapapa, Thomas Wirtz, Christian Rainer Henne-Bruns, Doris Kornmann, Marko |
author_facet | Lemke, Johannes Scheele, Jan Kapapa, Thomas Wirtz, Christian Rainer Henne-Bruns, Doris Kornmann, Marko |
author_sort | Lemke, Johannes |
collection | PubMed |
description | Pancreatic cancer is a fatal disease with a 5-year survival rate below 5%. Most patients are diagnosed at an advanced tumor stage and existence of distant metastases. However, involvement of the central nervous system is rare in pancreatic cancer. We retrospectively analyzed all cases of brain metastases in pancreatic cancer reported to date focusing on patient characteristics, clinical appearance, therapy and survival. Including our own, 12 cases of brain metastases originating from pancreatic cancer were identified. In three patients brain metastases were the first manifestation of pancreatic cancer. All other patients developed brain metastases during their clinical course. In most cases, the disease progressed rapidly and the patients died within weeks or months. However, two patients showed long-term survival. Of note, both patients received resection of the pancreatic cancer as well as curative resection of the metachronous brain metastases. Brain metastases in pancreatic cancer are a rare condition and usually predict a very poor prognosis. However, there is evidence that resection of brain metastases of pancreatic cancer can be immensely beneficial to patient’s survival, even with the chance for cure. Therefore, a surgical approach in metastatic pancreatic cancer should be considered in selective cases. |
format | Online Article Text |
id | pubmed-3588092 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-35880922013-03-13 Brain Metastasis in Pancreatic Cancer Lemke, Johannes Scheele, Jan Kapapa, Thomas Wirtz, Christian Rainer Henne-Bruns, Doris Kornmann, Marko Int J Mol Sci Review Pancreatic cancer is a fatal disease with a 5-year survival rate below 5%. Most patients are diagnosed at an advanced tumor stage and existence of distant metastases. However, involvement of the central nervous system is rare in pancreatic cancer. We retrospectively analyzed all cases of brain metastases in pancreatic cancer reported to date focusing on patient characteristics, clinical appearance, therapy and survival. Including our own, 12 cases of brain metastases originating from pancreatic cancer were identified. In three patients brain metastases were the first manifestation of pancreatic cancer. All other patients developed brain metastases during their clinical course. In most cases, the disease progressed rapidly and the patients died within weeks or months. However, two patients showed long-term survival. Of note, both patients received resection of the pancreatic cancer as well as curative resection of the metachronous brain metastases. Brain metastases in pancreatic cancer are a rare condition and usually predict a very poor prognosis. However, there is evidence that resection of brain metastases of pancreatic cancer can be immensely beneficial to patient’s survival, even with the chance for cure. Therefore, a surgical approach in metastatic pancreatic cancer should be considered in selective cases. MDPI 2013-02-19 /pmc/articles/PMC3588092/ /pubmed/23429199 http://dx.doi.org/10.3390/ijms14024163 Text en © 2013 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Lemke, Johannes Scheele, Jan Kapapa, Thomas Wirtz, Christian Rainer Henne-Bruns, Doris Kornmann, Marko Brain Metastasis in Pancreatic Cancer |
title | Brain Metastasis in Pancreatic Cancer |
title_full | Brain Metastasis in Pancreatic Cancer |
title_fullStr | Brain Metastasis in Pancreatic Cancer |
title_full_unstemmed | Brain Metastasis in Pancreatic Cancer |
title_short | Brain Metastasis in Pancreatic Cancer |
title_sort | brain metastasis in pancreatic cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3588092/ https://www.ncbi.nlm.nih.gov/pubmed/23429199 http://dx.doi.org/10.3390/ijms14024163 |
work_keys_str_mv | AT lemkejohannes brainmetastasisinpancreaticcancer AT scheelejan brainmetastasisinpancreaticcancer AT kapapathomas brainmetastasisinpancreaticcancer AT wirtzchristianrainer brainmetastasisinpancreaticcancer AT hennebrunsdoris brainmetastasisinpancreaticcancer AT kornmannmarko brainmetastasisinpancreaticcancer |